These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7940798)

  • 1. Effects of cyclosporine A on chronic renal transplant rejection.
    Pabico RC; Yarger J; Byer B; Kremer M; McKenna BA; Cerilli GJ
    Transplant Proc; 1994 Oct; 26(5):2577-9. PubMed ID: 7940798
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N; Zimmerman D; Klassen J
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
    Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
    Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic allograft rejection.
    Fan Y; Xie T; Xu D; Wang XH; Jin WH
    Chin Med J (Engl); 1993 Jul; 106(7):497-9. PubMed ID: 8243119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine increases endothelin-1 plasma levels in renal transplant recipients.
    Cauduro RL; Costa C; Lhulier F; Garcia RG; Cabral RD; Gonçalves LE; Manfro RC
    Transplant Proc; 2004 May; 36(4):880-1. PubMed ID: 15194301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine levels impact early rejection episodes.
    Granger DK; Amin NB; Sorenson AL; Gillingham KJ; Canafax DM; Matas AJ
    Transplant Proc; 1994 Oct; 26(5):2513. PubMed ID: 7940771
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.
    Oppenheimer F; Cofán F; Flores R; Pais B; Ochs J; Ricart MJ; Vilardell J; Campistol JM; Torregrosa JV
    Transplant Proc; 1994 Oct; 26(5):2516-7. PubMed ID: 7940773
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Yamazaki WM; Salgueiro MC; Silva ML; Ribeiro AC; Bezas AG
    Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A
    Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term safety profile of sandimmune in renal transplantation.
    Thiel G; Fellmann T; Rosman J; Bock A; Landmann J; Mihatsch M
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):71-7. PubMed ID: 1386702
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential clinical and immunological follow-up shows similar evolution during the first trimester after renal transplantation in patients receiving azathioprine or not.
    Renowt E; Béne C; Hestin D; Karleskind I; Faure G; Kessler M
    Clin Nephrol; 1992 Oct; 38(4):235-6. PubMed ID: 1424315
    [No Abstract]   [Full Text] [Related]  

  • 17. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract]   [Full Text] [Related]  

  • 18. Do steroids matter in one-haplotype pediatric renal allograft recipients on cyclosporine/azathioprine?
    David-Neto E; Ianhez LE; Nahas WC; Krasilcic S; Sabbaga E; Arap S
    Transplant Proc; 1994 Feb; 26(1):95-6. PubMed ID: 8109040
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 20. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.